Safety and Immunogenicity of 20vPnC in Toddlers With 2 Prior Doses of Prevenar 13

NCT05408429 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
356
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer